Trial · NCT00000400
Alendronate and/or Parathyroid Hormone for Osteoporosis
NCT00000400, Phase 2, Completed, Massachusetts General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Alendronate and/or Parathyroid Hormone for Osteoporosis. Trials, record NCT00000400. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00000400
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Alendronate and/or Parathyroid Hormone for Osteoporosis
- NCT number
- NCT00000400
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 176 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Osteoporosis
- Interventions
- Human parathyroid hormone [hPTH-(1-34)], alendronate
- First posted
- 1999-11-04
- Last updated
- 2013-12-09
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | change in spine bone mineral density | study months 30 (phase A), 42 (phase B), 54 (phase C) | |
| Secondary | change in hip bone mineral density | study months 30 (phase A), 42 (phase B), 54 (phase C) | |
| Secondary | change in forearm bone mineral density | study months 30 (phase A), 42 (phase B), 54 (phase C) | |
| Secondary | change in total body bone mineral | study months 30 (phase A), 42 (phase B), 54 (phase C) | |
| Secondary | change in femoral shaft bone mineral density | study months 30 (phase A), 42 (phase B), 54 (phase C) | |
| Secondary | change in serum PINP | study months 0-30 (phase A), 30-42 (phase B), 42-54 (phase C) | |
| Secondary | change in serum osteocalcin | study months 0-30 (phase A), 30-42 (phase B), 42-54 (phase C) | |
| Secondary | change in serum NTX | study months 0-30 (phase A), 30-42 (phase B), 42-54 (phase C) | |
| Secondary | incidence of hypercalcemia | study months 0-30 (phase A), 30-42 (phase B), 42-54 (phase C) | |
| Secondary | incidence of hypercalciuria | study months 0-30 (phase A), 30-42 (phase B), 42-54 (phase C) |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 19401368 | DERIVED |
Source PubMed
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| P50AR044855 | Specialized Center for Research in Osteoporosis | KRONENBERG, HENRY M | MASSACHUSETTS GENERAL HOSPITAL | NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES | 1997 to 2005 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00000400
GET https://conductscience.org/api/trials/v1/NCT00000400/registered